OVER THE PAST TWO DECADES, pathologists and lab managers have regularly watched certain new lab companies burst on the scene and generate startling growth in revenue and profits by offering proprietary tests–often unsupported by published clinical studies that demonstrate the utility of these tests.
- Lab Compliance Update
Why ‘Bad Actors’ Continue to Operate in Lab Industry
- By Robert Michel
- | From the Volume XXII No. 1 - January 5, 2015 Issue
